Pharvaris (PHVS) Assets Average (2021 - 2026)
Pharvaris (PHVS) posted Assets Average of $327.5 million for Q1 2026, down 12.32% on a QoQ basis from $373.5 million in Q4 2025, and up 14.46% year-over-year from $286.1 million in Q1 2025.
Pharvaris (PHVS) Assets Average (2021 - 2026) Analysis & Trends
Pharvaris' Assets Average history runs 6 years deep, the most recent figure standing at $327.5 million for Q1 2026.
- Quarterly Assets Average rose 14.46% year-over-year to $327.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $327.5 million (up 14.46% YoY) and the FY2025 annual result came in at $328.0 million, down 12.15% from the prior year.
- Assets Average was $327.5 million for Q1 2026 at Pharvaris, down from $373.5 million in the prior quarter.
- Across five years, Assets Average topped out at $419.6 million in Q1 2024 and bottomed at $164.9 million in Q1 2023.
- A 5-year average of $280.2 million and a median of $286.1 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average soared 154.47% — and 2025, when it tumbled 36.84%.
- Pharvaris' Assets Average stood at $187.9 million in 2022, then soared by 63.21% to $306.7 million in 2023, then advanced by 6.85% to $327.6 million in 2024, then gained by 14.01% to $373.5 million in 2025, then decreased by 12.32% to $327.5 million in 2026.
- Business Quant data shows PHVS's Assets Average at $327.5 million in Q1 2026, $373.5 million in Q4 2025, and $316.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.30 Bn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 327.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327.53 Mn |
| Dec 31, 2025 | 373.55 Mn |
| Sep 30, 2025 | 316.84 Mn |
| Jun 30, 2025 | 249.22 Mn |
| Mar 31, 2025 | 286.15 Mn |
| Dec 31, 2024 | 327.65 Mn |
| Sep 30, 2024 | 361.42 Mn |
| Jun 30, 2024 | 394.55 Mn |
| Mar 31, 2024 | 419.59 Mn |
| Dec 31, 2023 | 306.66 Mn |
| Sep 30, 2023 | 195.48 Mn |
| Jun 30, 2023 | 182.63 Mn |
| Mar 31, 2023 | 164.88 Mn |
| Dec 31, 2022 | 187.90 Mn |
| Sep 30, 2022 | 212.63 Mn |
| Jun 30, 2022 | 223.17 Mn |
| Mar 31, 2022 | 234.18 Mn |
| Dec 31, 2021 | 252.86 Mn |
| Sep 30, 2021 | 269.87 Mn |
| Jun 30, 2021 | 285.50 Mn |